您的购物车当前为空
别名 NSC-746045, IND-71677, BSI-201, 3-硝基-4-碘苯甲酰胺
Iniparib (BSI-201) 是一种不可逆的 PARP1抑制剂,在三阴性乳腺 Y 中表现出效力。


为众多的药物研发团队赋能,
让新药发现更简单!
Iniparib (BSI-201) 是一种不可逆的 PARP1抑制剂,在三阴性乳腺 Y 中表现出效力。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 179 | In stock | |
| 5 mg | ¥ 397 | In stock | |
| 10 mg | ¥ 651 | In stock | |
| 25 mg | ¥ 1,180 | In stock | |
| 50 mg | ¥ 1,930 | In stock | |
| 100 mg | ¥ 3,630 | In stock | |
| 200 mg | ¥ 5,230 | In stock | |
| 500 mg | ¥ 8,130 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 512 | In stock |
Iniparib 相关产品
| 产品描述 | Iniparib (BSI-201) (BSI-201) , a PARP1 inhibitor, exhibits potency in triple-negative breast Y (TNBC). |
| 体内活性 | 在855-2 细胞中, BSI-201(120 μM) 和buthionine sulfoximine联用可诱导细胞死亡达95%,作用于其他人类肿瘤细胞效果差不多。在E-ras 20 细胞中,BSI-201可抑制细胞生长,与buthionine sulfoximine联用,效果则增强20倍。人淋巴细胞系中,BSI-201(100 μM)可抑制电离辐射诱导的单链断裂 (SSBs) 修复。 |
| 细胞实验 | Cells are exposed to various concentrations of BSI-201 for 5, and 9 days in the presence or absence of buthionine sulfoxamide (BSO). After treatment, cell proliferation is measured by CellTiter-Glo assay.(Only for Reference) |
| 别名 | NSC-746045, IND-71677, BSI-201, 3-硝基-4-碘苯甲酰胺 |
| 分子量 | 292.03 |
| 分子式 | C7H5IN2O3 |
| CAS No. | 160003-66-7 |
| Smiles | N(=O)(=O)C1=CC(C(N)=O)=CC=C1I |
| 密度 | 2.055 g/cm3 (Predicted) |
| 颜色 | Red |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| 溶解度信息 | Ethanol: 14.6 mg/mL (49.99 mM), Sonication is recommended. DMSO: 85 mg/mL (291.07 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (11.3 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||
评论内容